ULURU Inc. Announces Common Stock to Begin Trading on OTCQB Marketplace

Apr 02, 2012, 07:30 ET from ULURU Inc.

ADDISON, Texas, April 2, 2012 /PRNewswire/ -- ULURU Inc. (OTCQB: ULUR), today announced that effective at the open of market on Monday, April 2, 2012, the Company's common stock will begin quotation and trading under the symbol "ULUR" on the OTCQB Marketplace, operated by OTC Markets Group.  The transition to the OTCQB Marketplace comes after the Company voluntarily delisted its common stock from the NYSE Amex, which became effective at the close of market on March 30, 2012.

Kerry P. Gray, President and CEO stated, "The Company has completed arrangements for the transition of its common stock to be quoted and traded on the OTCQB Marketplace.  We believe that the transition to the OTCQB Marketplace will save expenses and will allow for a continued orderly trading market for the Company's common stock as we continue to implement our business plan."

The transition of the ULURU's common stock to the OTCQB Marketplace does not change the Company's obligation to file periodic and other reports with the Securities and Exchange Commission under applicable federal securities laws. In addition, the transition of ULURU's common stock to the OTCQB Marketplace will have no effect on the shares themselves or our stockholders ability to trade ULURU's common stock on the OTCQB Marketplace.  

OTC Markets Group Inc. operates the world's largest electronic marketplace for broker-dealers to trade unlisted stocks, including the OTCQB Marketplace. Investors will be able to view the Real Time Level II stock quote, which provides detailed quote information by market maker, for ULURU Inc. at www.otcmarkets.com under the ticker symbol "ULUR".

About ULURU Inc.:
ULURU Inc. is a specialty pharmaceutical company focused on the development of a portfolio of wound management and oral care products to provide patients and consumers improved clinical outcomes through controlled delivery utilizing its innovative Nanoflex™ Aggregate technology and OraDisc™ transmucosal delivery system.  For further information about ULURU Inc., please visit our website at www.uluruinc.com.  For further information about Altrazeal®, please visit www.Altrazeal.com.

This press release contains certain statements that are forward-looking within the meaning of Section 27a of the Securities Act of 1933, as amended.  These statements are subject to numerous risks and uncertainties, including but not limited to the date of effectiveness of ULURU's quotation and trading on the OTCQB marketplace, expense savings and an orderly trading market as a result of transitioning to the OTCQB marketplace, and to risk factors detailed in the Company's Annual Report on Form 10-K for the year ended December 31, 2010, and other reports filed by us with the Securities and Exchange Commission.

Contact: Company
Kerry P. Gray
President & CEO
Terry K. Wallberg
Vice President & CFO
(214) 905-5145